Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
Using X-ray crystallography, researchers have "seen" the structural basis for antibiotic resistanc

Using X-ray crystallography, researchers have "seen" the structural basis for antibiotic resistanc

Researchers make gains in understanding antibiotic resistance

Researchers make gains in understanding antibiotic resistance

Antibiotic treatment does not reduce risk of secondary cardiac events

Antibiotic treatment does not reduce risk of secondary cardiac events

Invasive pneumonia and antibiotic resistance decreased after childhood streptococcus pneumoniae vaccine introduced

Invasive pneumonia and antibiotic resistance decreased after childhood streptococcus pneumoniae vaccine introduced

Immediate access to antibiotics stems spread of sexually transmitted diseases

Immediate access to antibiotics stems spread of sexually transmitted diseases

Study highlights the effectiveness of azithromycin (Zithromax) in reducing infection rates of trachoma

Study highlights the effectiveness of azithromycin (Zithromax) in reducing infection rates of trachoma

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections